Luxi Shen
Overview
Explore the profile of Luxi Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Chen Z, Shen Y, Xiong T, Chen A, Chen L, et al.
J Transl Med
. 2024 Aug;
22(1):760.
PMID: 39143479
Background: Alzheimer's disease (AD) is the most common neurogenerative disorder without effective treatments. Defects in mitochondrial complex I are thought to contribute to AD pathogenesis. The aim of this study...
2.
Li H, Zhang J, Shen Y, Ye Y, Jiang Q, Chen L, et al.
Biol Proced Online
. 2024 Apr;
26(1):9.
PMID: 38594619
Background: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), original found in synthetic heroin, causes Parkinson's disease (PD) in human through its metabolite MPP by inhibiting complex I of mitochondrial respiratory chain in dopaminergic neurons. This...
3.
Dai M, Qiao J, Shi Z, Wei X, Chen H, Shen L, et al.
Brain Stimul
. 2023 Jun;
16(4):1012-1020.
PMID: 37301470
Background: A 10-Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) could increase corticobulbar tract excitability in healthy individuals. However, its clinical efficacy for poststroke dysphagia (PSD) remains unclear. Objective: To investigate...
4.
Li H, Sun B, Huang Y, Zhang J, Xu X, Shen Y, et al.
Mol Med
. 2022 Mar;
28(1):29.
PMID: 35255803
Purpose: Parkinson's disease (PD) is the second most common neurodegenerative disease without cure or effective treatment. This study explores whether the yeast internal NADH-quinone oxidoreductase (NDI1) can functionally replace the...
5.
Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, et al.
Mol Med Rep
. 2022 Jan;
25(3).
PMID: 35039876
Animal models for Parkinson's disease (PD) are very useful in understanding the pathogenesis of PD and screening for new therapeutic approaches. The present study compared two commonly used neurotoxin‑induced mouse...
6.
Shen L, Li P, Zheng T, Luo M, Zhang S, Huang Y, et al.
Mol Med Rep
. 2021 Aug;
24(4).
PMID: 34368859
The present study aimed to provide evidence for the genetic heterogeneity of familial autism spectrum disorder (ASD), which might help to improve our understanding of the complex polygenic basis of...
7.
Jia L, Li F, Wei C, Zhu M, Qu Q, Qin W, et al.
Brain
. 2020 Nov;
144(3):924-937.
PMID: 33188687
Previous genome-wide association studies have identified dozens of susceptibility loci for sporadic Alzheimer's disease, but few of these loci have been validated in longitudinal cohorts. Establishing predictive models of Alzheimer's...
8.
Gannett C, Peterson B, Shen L, Seok J, Fors B, Abruna H
ChemSusChem
. 2020 Jan;
13(9):2428-2435.
PMID: 31975561
Developing cathodes that can support high charge-discharge rates would improve the power density of lithium-ion batteries. Herein, the development of high-power cathodes without sacrificing energy density is reported. N,N'-diphenylphenazine was...
9.
Jia L, Fu Y, Shen L, Zhang H, Zhu M, Qiu Q, et al.
Alzheimers Dement
. 2020 Jan;
16(1):178-191.
PMID: 31914229
Introduction: The PSENs/APP mutation distribution in Chinese patients with familial Alzheimer's disease (FAD) remains unclear. We aimed to analyze the genetic features of Chinese FAD pedigrees with and without PSENs/APP...
10.
Vitaku E, Gannett C, Carpenter K, Shen L, Abruna H, Dichtel W
J Am Chem Soc
. 2019 Dec;
142(1):16-20.
PMID: 31820958
Redox-active covalent organic frameworks (COFs) are promising materials for energy storage devices because of their high density of redox sites, permanent and controlled porosity, high surface areas, and tunable structures....